Taikang Asset Management Hong Kong Co Ltd Sells 17,262 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Taikang Asset Management Hong Kong Co Ltd cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 50.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 17,262 shares of the medical equipment provider's stock after selling 17,262 shares during the period. Intuitive Surgical accounts for 1.3% of Taikang Asset Management Hong Kong Co Ltd's investment portfolio, making the stock its 19th biggest position. Taikang Asset Management Hong Kong Co Ltd's holdings in Intuitive Surgical were worth $9,010,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. Bennett Selby Investments LP boosted its holdings in shares of Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock valued at $234,000 after acquiring an additional 17 shares during the last quarter. Onefund LLC lifted its position in Intuitive Surgical by 1.9% during the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock valued at $494,000 after purchasing an additional 18 shares during the period. LVW Advisors LLC boosted its holdings in Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after purchasing an additional 19 shares during the last quarter. Wesbanco Bank Inc. grew its position in Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock worth $635,000 after purchasing an additional 19 shares during the period. Finally, Journey Strategic Wealth LLC raised its stake in Intuitive Surgical by 1.9% during the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock valued at $542,000 after buying an additional 19 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Down 3.2 %

ISRG traded down $16.06 on Friday, hitting $491.84. 1,966,546 shares of the company's stock traded hands, compared to its average volume of 1,527,047. The company's 50 day simple moving average is $556.28 and its 200-day simple moving average is $532.68. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The firm has a market cap of $175.18 billion, a price-to-earnings ratio of 76.73, a P/E/G ratio of 5.85 and a beta of 1.43.

Insider Activity

In other news, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the business's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock worth $17,691,621 over the last quarter. Insiders own 0.90% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on ISRG. Morgan Stanley upgraded Intuitive Surgical from an "equal weight" rating to an "overweight" rating and raised their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Leerink Partners increased their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. CICC Research assumed coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a "neutral" rating and a $550.00 target price for the company. Finally, Royal Bank of Canada upped their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.